VELOCITY
SCOPE CIMSA UKDW
Antimicrobial resistance has drastically risen lately and has become a global health and development threat. WHO declared that AMR is one of the top 10 global public health threats facing humanity. To tackle this rising number, SCOPE CIMSA UKDW held a VELOCITY project (Travel the World With SCOPE) in the form of the webinar that brought the central theme "Antimicrobial Resistance from Global Perspective." The webinar was held on Saturday, March 6th, 2021, inviting a competent speaker in microbiology, Dr. drg. Michaela Maryani Suryani Hutomo, Master of Dental Science.
The webinar was started by opening a master of ceremony (MC), Sinta, and Vinaldee. It was a fun atmosphere in the room, even at the beginning. After the introduction from MC, Reisya, as moderator, took control of the webinar to lead the speaker's main session. However, as usual, before receiving all the excellent knowledge and information from drg. Suryani, there was a pretest.
The pretest was a measurement of how far the participant is prior knowledge regarding the topic—moving on to the most awaited session, drg. Suryani explained eye-opener information about the use of antibiotics. Detailed information that we never knew we needed, and some misperceptions of the use of antibiotics, one of them and surprisingly a shocking fact is not taking all the antibiotics as prescribed. This webinar enlightens us on how this common mistake could make the bacterias even stronger. It was all mindblowing, isn't it? QnA and participants who followed the session were so excited to know more. Sadly, because of the limited time, the discussion needed to end. All the participants, committees, and speakers also took some documentations via Zoom. Right away, to measure the improvement knowledge of participants, there was a post-test. Although the event was coming to an end yet, the hype was still going on because of the fun icebreaking from the MC and, of course, with door prizes. We hope this webinar brought up good impacts and a new perspective of antimicrobial resistance.
